SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-16-011563
Filing Date
2016-01-12
Accepted
2016-01-12 17:30:33
Documents
1
Period of Report
2016-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1569
  Complete submission text file 0000899243-16-011563.txt   3114
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 131 HARTWELL AVE LEXINGTON MA 02421
Business Address
Clark David J (Reporting) CIK: 0001662693 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36332 | Film No.: 161339513